Protein C inhibitor is expressed in keratinocytes of human skin

Journal of Investigative Dermatology

Volumn 113, Issue 1, 1999, Pages 32-37

  Krebs, Michael ^a   Uhrin, Pavel ^a   Vales, Anja ^a   Prendes Garcia, Maria J ^a   Wojta, Johann ^a   Geiger, Margarethe ^a   Binder, Bernd R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Epidermis; Plasminogen activator inhibitor; Serine protease inhibitor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 3;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032775236     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00644.x     Document Type: Article

References (36)

1. Barker JN, Mitra RS, Griffiths CE, Dixit CE, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 337:211-214, 1991
2. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD: Upregulation of cell surface associated plasminogen activation in cultured keratinocytes by interleukin-1β and tumor necrosis factor-α. Exp Cell Res 223:395-404, 1996
3. Belin D: Biology and facultative secretion of plasminogen activator inhibitor-2. Thromb Haemostas 70:144-147, 1993
4. Boukamp P, Dzarliewa-Perusevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
5. Breitkreutz D, Schoop VM, Mirancea N, Baur M, Stark HJ, Fusenig NE: Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Biol 75:273-286, 1998
6. Carroll VA, Griffith MR, Geiger M, Merlo C, Furlan M, Lämmle B, Binder BR: Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arteriosclerosis Thromb Vasc Biol 17:114-118, 1997
7. Chen CS, Lyons-Giordano B, Lazarus GS, Jensen PJ: Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. J Cell Sci 106:45-53, 1993
8. Cooper ST, Church FC: Reactive site mutants of recombinant protein C inhibitor. Biochim Biophys Acta 1246:29-33, 1995
9. Ecke S, Geiger M, Resch I, Jerabeck I, Stingl L, Maier M, Binder BR: Inhibition of tissue kallikrein by protein C inhibitor. J Biol Chem 267(10):7048-7052, 1992
10. Espana F, Vicente V, Tabemero D, Scharrer I, Griffin JH: Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res 59:593-608, 1990
11. Fair DS, Marlar RA: Biosynthesis and secretion of factor VII, protein C, protein S, and the protein C inhibitor from a human hepatoma cell line. Blood 67: 64-70, 1986
12. Fisher GJ, Voorhees JJ: Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013, 1996
13. Flink IL, Bailey TJ, Gustafson TA, Markham BE, Morkin E: Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA. Close homology to the serine antiproteases. Proc Natl Acad Sci USA 83:7708-7712, 1986
14. Francis RB, Thomas W: Behaviour of protein C inhibitor in intravascular coagulation and liver disease. Thromb Haemostas 52:71-74, 1984
15. Geiger M, Huber K, Wojta J, Stingl L, Espana F, Griffin JH, Binder BR: Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. Blood 74:722-728, 1989
16. Geiger M, Zechmeister-Machhart M, Uhrin P, et al: Protein C inhibitor (PCI). Immunopharmacology 32:53-56, 1996
17. Geiger M, Krebs M, Jerabek I, Binder BR: Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system. Immunopharmacology 36:279-284, 1997
18. Hammond GL, Smith CL, Goping IS, et al: Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA 84:5153-5157, 1987
19. Harper PL, Carrell RW: The serpins. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). Haemostasis and Thrombosis, Vol. 3. Edinburgh: Churchill Livingstone, 1994, pp 641-653
20. Jensen PJ, John M, Baird J: Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187:162-169, 1990
21. Jensen PJ, Wu Q, Janowitz P, Ando Y, Schechter NM: Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp Cell Res 217:65-71, 1995
22. Laurell M, Christensson A, Abrahamsson P, Stenflo J, Lilja H: Protein C inhibitor in human body fluids. J Clin Invest 89:1094-1101, 1992
23. Lyons-Giordano B, Loskutoff D, Chen CS, Lazarus G, Keeton M, Jensen PJ: Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Histochemistry 101:105-112, 1994
24. Marlar RA, Griffin JH: Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 66(5):1186-1189, 1980
25. Morito F, Saito H, Suzuki K, Hashimoto S: Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2. Biochem Biophys Acta 884:209-215, 1985
26. Poblete MT, Reynolds NJ, Figueroa CD, Burton JL, Muller-Esterl W, Bhoola KD: Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br J Dermatol 124:236-241, 1991
27. Priglinger U, Geiger M, Bielek E, Vanyek E, Binder BR: Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCI,-598). J Biol Chem 269(20):14705-14710, 1994
28. Radtke KP, Fernández JA, Greengard JS, et al: Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 94:2117-2124, 1994
29. Reinartz J, Link J, Todd RF, Kramer MD: The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT). Exp Cell Res 214:486-498, 1994
30. Reinartz J, Schaefer B, Bechtel M, Kramer MD: Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator. Exp Cell Res 223:91-101, 1996
31. Schremmer Danninger E, Heinz-Erian P, Töpfer-Petersen E, Roscher AA: Autoradiographic localization and characterization of bradykinin receptors in human skin. Eur J Pharmacol 283:207-216, 1995
32. Scicli AG, Carretero OA: Renal kallikrein-kinin system. Kidney Int 29:120-130, 1986
33. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S: Mechanism of inhibition of activated protein C inhibitor. J Biochem 95:187-195, 1984
34. Suzuki K, Deyashiki Y, Nishioka J, Toma K: Protein C inhibitor: Structure and function. Thromb Haemostas 61 (3):337-342, 1989
35. Thorsen S, Philips M, Selmer J, Lecander I, Astedt B: Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2. Eur J Biochem 175:33-39, 1988
36. Zheng X, Geiger M, Ecke S, et al: Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am J Physiol 267:C466-C472, 1994